Mass trial of repurposed MS drug for Covid begins at hospital in Hull

A mass trial of a repurposed Multiple Sclerosis drug that researchers hope will hugely reduce the chances of coronavirus patients becoming seriously ill has begun at a hospital in Hull.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news